Table 2 Comparison of Clinical features between MDA and non-MDA GAS
Clinical features | MDA | Non-MDA | P value |
|---|---|---|---|
Age (median, IQR) | 46 (42.0, 62.0) | 48 (40.5, 59.0) | 0.86 |
Symptoms (n, %) | 0.34 | ||
Bleeding | 7 (53.8%) | 11 (78.6%) | |
discharge | 6 (46.2%) | 3 (21.4%) | |
Tumor Size in the greatest dimension (n, %) | 0.56 | ||
< 4 cm | 8 (47.1%) | 13 (61.9%) | |
≥ 4 cm | 9 (52.9%) | 8 (38.1%) | |
TCT (n, %) | 0.06 | ||
NILM | 7 (63.6%) | 3 (20.0%) | |
Abnormal | 4 (36.4%) | 12 (80.0%) | |
Stage (n, %) | 0.83 | ||
I-IIA | 8 (47.1%) | 9 (45.0%) | |
IIB-IV | 9 (52.9%) | 11 (55.0%) | |
Lymph node metastasis (n, %) | 0.95 | ||
Negative | 10 (66.7%) | 14 (73.7%) | |
Positive | 5 (33.3%) | 5 (26.3%) | |
Deep stromal invasive (n, %) | 0.43 | ||
Negative | 3 25.0%) | 1 (5.3%) | |
positive | 12 (75.0%) | 18 (94.7%) | |
LVSI (n, %) | 0.44 | ||
Negative | 10 (66.7%) | 9 (47.4%) | |
positive | 5 (33.3%) | 10 (52.6%) |